"Approach it Like a Pro" is based on the professional practices of a leading rheumatologist, and two first-hand accounts from real patients. This brief documentary-style video explores some real-life implications of psoriatic arthritis and moderately to severely active rheumatoid arthritis, and offers exclusive insights into the treatment journey.
“It’s exciting to see improvements in signs and symptoms of moderate to severe RA and psoriatic arthritis. It helps patients gain confidence in their treatment.”
—Dr. Phil Mease
Individual results may vary.
Meet the Pros
Dr. Phil Mease
Leading rheumatologist who's helped design key clinical studies that have impacted treatment guidelines and helped establish current therapies.
Professional golfer who worked with his doctor to take a proactive approach to managing his psoriatic arthritis.
Wife and mother of five. She's also an ER nurse and health educator and has been living with moderately to severely active rheumatoid arthritis for several years.
In medical studies, ENBREL was shown to be clinically effective in about 2 out of 3 adults with moderate to severe RA at 3 months. ENBREL has been shown to begin working in as few as 2 weeks, and most patients who benefit will do so within 3 months. In another medical study, 55% of patients who were evaluated 5 years after beginning ENBREL therapy had no further progression of joint damage.
In a medical study, ENBREL was shown to be effective in about 50% of psoriatic arthritis patients at 6 months. Clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy.